compounds, the cancer cell death has been preceded by massive accumulation of intracellular vacuoles, but the molecular targets of these drugs are still unknown.
The identification of the targets of vacquinols and chalcones, as well as the alternative methods to manipulate the endocytic pathways of cancer cells, will strongly benefit from a better characterization of molecular mechanisms leading to aberrant vacuolation, a prerequisite for tumor death by methuosis.
In this issue of American Journal of Physiology-Cell Physiology, Compton et al. (1) provide new insights into the mechanisms involved in accumulation of large cytosolic vacuoles that affect cellular viability. The authors inactivate Vps34 or PIKfyve using pharmacological or genetic approaches. As expected, inactivation of Vps34 or PIKfyve induced a depletion of intracellular levels of PtdIns(3,5)P 2 and the accumulation of aberrant large vacuoles in the cytosol. This effect relied on the activation of the small GTPase Rab5 and of the vacuolar H ϩ ATPase. Requirement of Rab5 GTPase activity, as demonstrated by expression of dominant-negative mutant of Rab5, the GFP-Rab5 S34N mutant protein, which rescued the aberrant vacuolation phenotype, even if Vps34 or PIKfyve were inactivated. These data indicated that the GTP-GDP Rab5 cycle is essential for endosome fusion and growth of intracellular large vacuoles that resemble early steps in endosome maturation. The implication of vacuolar Hϩ ATPase was demonstrated by a pharmacological approach, using the macrolide antibiotic bafilomycin A1. Bafilomycin A1 treatment rescued and prevented the formation of cytosolic vacuoles due to Vps34 or PIKfyve inhibition. Nevertheless, this protective effect of bafilomycin A1 was probably independent of the alkalinization of endosomal pathways by the drug, as suggested by the lack of effect of NH 4 Cl or chloroquine, two compounds that increase the endocytic pH but did not rescue the vacuolation phenotype induced by Vps34 or PIKfyve inactivation. These results suggested that the H ϩ V-ATPase display pH-independent activities through a mechanism that remains to be identified. Alternatively, bafilomycin A1 may also impact on the aberrant vacuoles formation via inhibition of heterotypic and/or homotypic endosome fusion (2) (1, 9) . In these conditions, the fusion of early endosomal vesicles generates an abnormal accumulation of large intracellular vacuoles. Compton et al. (1) established that Rab5 activity is absolutely required for this phenomenon, while bafilomycin A1 inhibits the process. Modulation of Rab5 activity, inhibition of Vps34 or discovery of the molecular mechanism by which bafilomycin A1 inhibits vacuolation might offer new strategies to induce cancer cell death through aberrant vacuolation.
